Pay in 4 interest-free payments of $5.45 Learn more
Ships within 48 hours · Estimated delivery Aug 20 - Aug 25
Two patients on the same platform can pay different totals, which is why a single advertised number rarely reflects real out-of-pocket spend
Due to supply constraints and commissioning restrictions, many patients currently access these medications through private prescription
Payment Options Prepaid Orders: Free Delivery Cash on Delivery (COD) : 25% advance payment required 300 COD shipping charge (Advance payment helps us avoid fake orders and ensures faster dispatch.) Dispatch & Delivery Dispatch Time: 2448 working hours Delivery: Pan-India coverage Estimated Delivery: Metro Cities: 24 working days Other Locations: 37 working days (Delivery time may vary due to location, weather, or courier delays.) Tracking: Shared via WhatsApp / SMS after dispatch Important Delivery Notes Please ensure your address and contact number are accurate Orders once shipped cannot be cancelled or redirected Refused or unclaimed COD orders may affect future COD eligibility Packaging & Privacy Tamper-proof sealed packaging Discreet outer box 100% customer privacy maintained Trusted Courier Partners We ship only through reliable national courier services : DTDC Blue Dart Ekart Delhivery Trust & Assurance 100% Genuine Products Verified & Trusted Seller Secure Delivery Network Pan-India Shipping Related products Denik Pharma Beta Trutide | 5mg 20,899.00 - 21,999.00 You save
Global Glp 1 Analogues Market Market Size in USD Billion GLP-1 Analogues Market Size The global GLP-1 analogues market size was valued at USD 32.19 billion in 2024 and is expected to reach USD 346.06 billion by 2032 , at a CAGR of 34.56% during the forecast period This growth is driven by factors such as the rising global prevalence of obesity and type 2 diabetes, along with increasing adoption of GLP-1 analogues due to their effectiveness in glycemic control and weight management GLP-1 Analogues Market Analysis GLP-1 (glucagon-like peptide-1) analogues are injectable drugs used primarily for the treatment of type 2 diabetes and obesity, improving blood sugar control and aiding in weight loss by mimicking the GLP-1 hormone The market growth is significantly driven by the increasing global prevalence of obesity and type 2 diabetes, along with growing awareness of the benefits of GLP-1 analogues in weight management North America is expected to lead the GLP-1 analogues market with with an estimated market share of over 76.05%, due to high obesity rates, robust healthcare systems, and early adoption of advanced therapies Asia-Pacific is projected to witness the fastest growth owing to rising diabetic population, healthcare access improvements, and expanding awareness of chronic disease management Ozempic segment is expected to dominate the market with a market share of 34.67% due to its proven efficacy in lowering HbA1c levels and promoting significant weight loss in patients with type 2 diabetes
Homozygous NKO mice exhibit embryonic lethality [68], whereas heterozygous NKO mice exhibit IGT due to impaired insulin secretion [68] and heart failure due to progressive mitochondrial dysfunction induced by pressure overload [69]
Glucagon-like peptide-1 receptor co-agonists for treating metabolic disease
